Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
Toxicol In Vitro ; 27(4): 1357-76, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22922246

ABSTRACT

ACuteTox is a project within the 6th European Framework Programme which had as one of its goals to develop, optimise and prevalidate a non-animal testing strategy for predicting human acute oral toxicity. In its last 6 months, a challenging exercise was conducted to assess the predictive capacity of the developed testing strategies and final identification of the most promising ones. Thirty-two chemicals were tested blind in the battery of in vitro and in silico methods selected during the first phase of the project. This paper describes the classification approaches studied: single step procedures and two step tiered testing strategies. In summary, four in vitro testing strategies were proposed as best performing in terms of predictive capacity with respect to the European acute oral toxicity classification. In addition, a heuristic testing strategy is suggested that combines the prediction results gained from the neutral red uptake assay performed in 3T3 cells, with information on neurotoxicity alerts identified by the primary rat brain aggregates test method. Octanol-water partition coefficients and in silico prediction of intestinal absorption and blood-brain barrier passage are also considered. This approach allows to reduce the number of chemicals wrongly predicted as not classified (LD50>2000 mg/kg b.w.).


Subject(s)
Neural Networks, Computer , Toxicity Tests, Acute , Administration, Oral , Animal Testing Alternatives , Animals , Blood-Brain Barrier/metabolism , Cell Line , Cell Survival , Colony-Forming Units Assay , Computer Simulation , Cytokines/metabolism , Humans , Intestinal Absorption , Lethal Dose 50 , Mice , Oxidative Stress , Rats , Risk Assessment
2.
Neuroscience ; 187: 84-92, 2011 Jul 28.
Article in English | MEDLINE | ID: mdl-21549181

ABSTRACT

Minocycline has been shown to inhibit microglia reactivity, and to decrease the severity and progression of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. It remained to be examined whether minocycline was also able to promote remyelination. In the present study, myelinating aggregating brain cell cultures were used as a model to study the effects of minocycline on microglial reactivity, demyelination, and remyelination. Cultures were treated simultaneously with two inflammatory agents, interferon-γ (IFN-γ) and lipopolysaccharide (LPS), which caused an inflammatory response accompanied by demyelination. The inflammatory response was characterized by microglial reactivity, upregulation of inflammatory cytokines and iNOS, and increased phophorylation of P38 and P44/42 mitogen activated protein (MAP) kinases. Minocycline inhibited microglial reactivity, and attenuated the increased phophorylation of P38 and P44/42 MAP kinases. Demyelination, determined by a decrease in myelin basic protein (MBP) content and immunoreactivity 48 h after the treatment with the inflammatory agents, was not prevented by minocycline. However, 1 week after demyelination was assessed, the MBP content was restored in presence of minocycline, indicating that remyelination was promoted. Concomitantly, in cultures treated with minocycline, the markers of oligodendrocyte precursors cells (OPCs) and immature oligodendrocytes NG2 and O4, respectively, were decreased compared to cultures treated with the inflammatory agents only. These results suggest that minocycline attenuates microglial reactivity and favors remyelination by enhancing the differentiation of OPCs and immature oligodendrocytes.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Cell Differentiation/drug effects , Demyelinating Diseases/metabolism , Minocycline/pharmacology , Oligodendroglia/drug effects , Animals , Blotting, Western , Brain/drug effects , Brain/metabolism , Cells, Cultured , Demyelinating Diseases/chemically induced , Enzyme Activation/drug effects , Immunohistochemistry , Interferon-gamma/toxicity , Lipopolysaccharides/toxicity , Neurons/drug effects , Neurons/metabolism , Oligodendroglia/cytology , Rats , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Stem Cells/drug effects
3.
Toxicol In Vitro ; 24(4): 1053-63, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20362047

ABSTRACT

Quality assurance is becoming increasingly important. Good laboratory practice (GLP) and good manufacturing practice (GMP) are now established standards. The biomedical field aims at an increasing reliance on the use of in vitro methods. Cell and tissue culture methods are generally fast, cheap, reproducible and reduce the use of experimental animals. Good cell culture practice (GCCP) is an attempt to develop a common standard for in vitro methods. The implementation of the use of chemically defined media is part of the GCCP. This will decrease the dependence on animal serum, a supplement with an undefined and variable composition. Defined media supplements are commercially available for some cell types. However, information on the formulation by the companies is often limited and such supplements can therefore not be regarded as completely defined. The development of defined media is difficult and often takes place in isolation. A workshop was organised in 2009 in Copenhagen to discuss strategies to improve the development and use of serum-free defined media. In this report, the results from the meeting are discussed and the formulation of a basic serum-free medium is suggested. Furthermore, recommendations are provided to improve information exchange on newly developed serum-free media.


Subject(s)
Cell Culture Techniques/methods , Culture Media, Serum-Free/chemistry , Animal Testing Alternatives , Animals , Cattle , Fetal Blood/chemistry , Information Dissemination , Mammals , Serum/chemistry , Tissue Culture Techniques/methods
4.
Toxicol In Vitro ; 23(8): 1564-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19615435

ABSTRACT

The objective of the EU funded integrated project "ACuteTox" is to develop a strategy in which general cytotoxicity, together with organ-specific endpoints and biokinetic features, are taken into consideration in the in vitro prediction of oral acute systemic toxicity. With regard to the nervous system, the effects of 23 reference chemicals were tested with approximately 50 endpoints, using a neuronal cell line, primary neuronal cell cultures, brain slices and aggregated brain cell cultures. Comparison of the in vitro neurotoxicity data with general cytotoxicity data generated in a non-neuronal cell line and with in vivo data such as acute human lethal blood concentration, revealed that GABA(A) receptor function, acetylcholine esterase activity, cell membrane potential, glucose uptake, total RNA expression and altered gene expression of NF-H, GFAP, MBP, HSP32 and caspase-3 were the best endpoints to use for further testing with 36 additional chemicals. The results of the second analysis showed that no single neuronal endpoint could give a perfect improvement in the in vitro-in vivo correlation, indicating that several specific endpoints need to be analysed and combined with biokinetic data to obtain the best correlation with in vivo acute toxicity.


Subject(s)
Neurons/drug effects , Toxicity Tests, Acute/methods , Animals , Blood-Brain Barrier , Cell Line , Humans , Lethal Dose 50 , Membrane Potentials/drug effects , Mice , Rats , Receptors, GABA-A/drug effects , Receptors, GABA-A/physiology
5.
Hum Exp Toxicol ; 26(4): 339-46, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17615115

ABSTRACT

Brain inflammatory response is triggered by the activation of microglial cells and astrocytes in response to various types of CNS injury, including neurotoxic insults. Its outcome is determined by cellular interactions, inflammatory mediators, as well as trophic and/or cytotoxic signals, and depends on many additional factors such as the intensity and duration of the insult, the extent of both the primary neuronal damage and glial reactivity and the developmental stage of the brain. Depending on particular circumstances, the brain inflammatory response can promote neuroprotection, regeneration or neurodegeneration. Glial reactivity, regarded as the central phenomenon of brain inflammation, has also been used as an early marker of neurotoxicity. To study the mechanisms underlying the glial reactivity, serum-free aggregating brain cell cultures were used as an in vitro model to test the effects of conventional neurotoxicants such as organophosphate pesticides, heavy metals, excitotoxins and mycotoxins. This approach was found to be relevant and justified by the complex cell-cell interactions involved in the brain inflammatory response, the variability of the glial reactions and the multitude of mediators involved. All these variables need to be considered for the elucidation of the specific cellular and molecular reactions and their consequences caused by a given chemical insult.


Subject(s)
Brain/pathology , Inflammation/chemically induced , Inflammation/pathology , Neurotoxicity Syndromes/pathology , Brain/growth & development , Cells, Cultured , Cytological Techniques , Glial Fibrillary Acidic Protein/metabolism , Humans , Neuroglia/pathology , Neurons/pathology
6.
Neuroscience ; 134(3): 771-82, 2005.
Article in English | MEDLINE | ID: mdl-15994020

ABSTRACT

Ochratoxin A (OTA), a mycotoxin and widespread food contaminant, is known for its patent nephrotoxicity and potential neurotoxicity. Previous observations in vitro showed that in the CNS, glial cells were particularly sensitive to OTA. In the search for the molecular mechanisms underlying OTA neurotoxicity, we investigated the relationship between OTA toxicity and glial reactivity, in serum-free aggregating brain cell cultures. Using quantitative reverse transcriptase-polymerase chain reaction to analyze changes in gene expression, we found that in astrocytes, non cytotoxic concentrations of OTA down-regulated glial fibrillary acidic protein, while it up-regulated vimentin and the peroxisome proliferator-activated receptor-gamma expression. OTA also up-regulated the inducible nitric oxide synthase and the heme oxygenase-1. These OTA-induced alterations in gene expression were more pronounced in cultures at an advanced stage of maturation. The natural peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-delta(12,14) prostaglandin J2, and the cyclic AMP analog, bromo cyclic AMP, significantly attenuated the strong induction of peroxisome proliferator-activated receptor-gamma and inducible nitric oxide synthase, while they partially reversed the inhibitory effect of OTA on glial fibrillary acidic protein. The present results show that OTA affects the cytoskeletal integrity of astrocytes as well as the expression of genes pertaining to the brain inflammatory response system, and suggest that a relationship exists between the inflammatory events and the cytoskeletal changes induced by OTA. Furthermore, these results suggest that, by inducing an atypical glial reactivity, OTA may severely affect the neuroprotective capacity of glial cells.


Subject(s)
Astrocytes/drug effects , Gene Expression Regulation/drug effects , Mycotoxins/pharmacology , Ochratoxins/pharmacology , Animals , Astrocytes/physiology , Brain/cytology , Cell Aggregation/drug effects , Cells, Cultured , Culture Media, Serum-Free/pharmacology , Cyclic AMP/metabolism , Cyclic AMP/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Embryo, Mammalian , Extracellular Fluid/drug effects , Extracellular Fluid/metabolism , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Glutamate-Ammonia Ligase/genetics , Glutamate-Ammonia Ligase/metabolism , Heme Oxygenase (Decyclizing)/genetics , Heme Oxygenase (Decyclizing)/metabolism , Heme Oxygenase-1 , Hydro-Lyases/metabolism , Immunohistochemistry/methods , In Situ Hybridization/methods , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , PPAR gamma/genetics , PPAR gamma/metabolism , Prostaglandin D2/analogs & derivatives , Prostaglandin D2/pharmacology , RNA, Messenger/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction/methods , Time Factors , Vimentin/genetics , Vimentin/metabolism
7.
Toxicol Appl Pharmacol ; 201(2): 97-104, 2004 Dec 01.
Article in English | MEDLINE | ID: mdl-15541749

ABSTRACT

An in vitro model, the aggregating brain cell culture of fetal rat telencephalon, has been used to investigate the influence of glial cells on the neurotoxicity of two organophosphorus pesticides (OPs), chlorpyrifos and parathion. Mixed-cell aggregate cultures were treated continuously for 10 days between DIV 5 and 15. Parathion induced astrogliosis at concentration at which MAP-2 immunostaining, found here to be more sensitive than neuron-specific enzyme activities, was not affected. In contrast, chlorpyrifos induced a comparatively weak gliotic reaction, and only at concentrations at which neurons were already affected. After similar treatments, increased neurotoxicity of parathion and chlorpyrifos was found in aggregate cultures deprived of glial cells. These results suggest that glial cells provide neuroprotection against OPs toxicity. To address the question of the difference in toxicity between parathion and chlorpyrifos, the toxic effects of their leaving groups, p-nitrophenol and trichloropyridinol, were studied in mixed-cell aggregates. General cytotoxicity was more pronounced for trichloropyridinol and both compounds had similar toxic effects on neuron-specific enzyme activities. In contrast, trichloropyridinol induced a much stronger decrease in glutamine synthetase activity, the enzymatic marker of astrocytes. Trichloropyridinol may exert a toxic effect on astrocytes, compromising their neuroprotective function, thus exacerbating the neurotoxicity of chlorpyrifos. This is in line with the suggestion that glial cells may contribute to OPs neurotoxicity, and with the view that OPs may exert their neurotoxic effects through different mechanisms.


Subject(s)
Chlorpyrifos/analogs & derivatives , Chlorpyrifos/toxicity , Cholinesterase Inhibitors/toxicity , Insecticides/toxicity , Neuroglia/pathology , Neurotoxicity Syndromes/pathology , Parathion/toxicity , Acetylcholinesterase/metabolism , Animals , Astrocytes/pathology , Brain/cytology , Cells, Cultured , Chlorpyrifos/metabolism , Choline O-Acetyltransferase/metabolism , Glutamate Decarboxylase/metabolism , Glutamate-Ammonia Ligase/metabolism , Immunohistochemistry , L-Lactate Dehydrogenase/metabolism , Paraoxon/metabolism , Paraoxon/toxicity , Protein Binding , Rats
8.
J Neurosci Res ; 71(4): 583-90, 2003 Feb 15.
Article in English | MEDLINE | ID: mdl-12548715

ABSTRACT

Trimethyltin (TMT) is a neurotoxicant known to induce early microglial activation. The present study was undertaken to investigate the role played by these microglial cells in the TMT-induced neurotoxicity. The effects of TMT were investigated in monolayer cultures of isolated microglia or in neuron-enriched cultures and in neuron-microglia and astrocyte-microglia cocultures. The end points used were morphological criteria; evaluation of cell death and cell proliferation; and measurements of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and nitric oxide (NO) release in culture supernatant. The results showed that, in cultures of microglia, TMT (10(-6) M) caused, after a 5-day treatment, an increased release of TNF-alpha, without affecting microglial shape or cell viability. When microglia were cocultured with astrocytes, TNF-alpha release was decreased to undetectable levels. In contrast, in neuron-microglia cocultures, TNF-alpha levels were found to increase at lower concentrations of TMT (i.e., 10(-8) M). Moreover, at 10(-6) M of TMT, microglia displayed further morphological activation, as suggested by process retraction and by decrease in cell size. No morphological activation was observed in cultures of isolated microglial cells and in astrocyte-microglia cocultures. With regard to neurons, 10(-6) M of TMT induced about 30% of cell death, when applied to neuron-enriched cultures, whereas close to 100% of neuronal death was observed in neuron-microglia cocultures. In conclusion, whereas astrocytes may rather dampen the microglial activation by decreasing microglial TNF-alpha production, neuronal-microglial interactions lead to enhanced microglial activation. This microglial activation, in turn, exacerbates the neurotoxic effects of TMT. TNF-alpha may play a major role in such cell-cell communications.


Subject(s)
Microglia/drug effects , Nerve Degeneration/metabolism , Neurons/drug effects , Trimethyltin Compounds/toxicity , Tumor Necrosis Factor-alpha/metabolism , Animals , Cell Communication/drug effects , Cell Communication/physiology , Cells, Cultured , Microglia/metabolism , Microglia/pathology , Nerve Degeneration/pathology , Neurons/metabolism , Neurons/pathology , Rats
9.
J Neurosci Res ; 65(5): 446-54, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11536329

ABSTRACT

To link the presence of intrathecal virus-specific oligoclonal immunoglobulin G (IgG) in multiple sclerosis patients to a demyelinating activity, aggregating rat brain cell cultures were treated with antibodies directed against two viruses, namely, rubella (RV) and hepatitis B (HB). Anti-RV antibodies in the presence of complement decreased myelin basic protein concentrations in a dose-dependent manner, whereas anti-HB antibodies had no effect. A similar but less pronounced effect was observed on the enzymatic activity of 2',3'-cyclic nucleotide 3'-phosphohydrolase, which is enriched in noncompact membranes of oligodendrocytes. These effects were comparable to those in cultures treated with antibodies directed against myelin oligodendrocyte glycoprotein (MOG), previously found to be myelinotoxic both in vitro and in vivo. Sequence homologies were found between structural glycoprotein E(2) of RV and MOG, suggesting that demyelination was due to molecular mimicry. To support the hypothesis that demyelination was caused by anti-RV IgG that recognized an MOG epitope, we found that anti-RV antibodies depleted MOG in a dose-dependent manner. Further evidence came from the demonstration that anti-RV and anti-MOG IgG colocalized on oligodendrocyte processes and that both revealed by Western blot a 28 kDa protein in CNS myelin, a molecular weight corresponding to MOG. These findings suggest that a virus such as RV exhibiting molecular mimicry with MOG can trigger an autoimmune demyelination.


Subject(s)
Antibodies/pharmacology , Cells, Cultured/drug effects , Multiple Sclerosis/virology , Myelin Sheath/drug effects , Myelin-Associated Glycoprotein/immunology , Rubella virus/immunology , Viral Envelope Proteins/immunology , Animals , Antibodies/immunology , Antibody Specificity/immunology , Astrocytes/cytology , Astrocytes/drug effects , Astrocytes/immunology , Brain/drug effects , Brain/immunology , Brain/virology , Cell Aggregation/immunology , Cells, Cultured/immunology , Cells, Cultured/virology , Cross Reactions/immunology , Fetus , Immunoglobulin G/immunology , Immunohistochemistry , Multiple Sclerosis/immunology , Multiple Sclerosis/physiopathology , Myelin Proteins , Myelin Sheath/immunology , Myelin Sheath/virology , Myelin-Associated Glycoprotein/deficiency , Myelin-Oligodendrocyte Glycoprotein , Neurons/cytology , Neurons/drug effects , Neurons/immunology , Oligodendroglia/cytology , Oligodendroglia/drug effects , Oligodendroglia/immunology , Rats , Rubella virus/metabolism , Rubella virus/pathogenicity , Viral Envelope Proteins/metabolism
10.
Neurochem Res ; 26(6): 619-27, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11519722

ABSTRACT

In previous work we found that mezerein, a C kinase activator, as well as basic fibroblast growth factor (FGF-2) induce demyelination and partial oligodendrocyte dedifferentiation in highly differentiated aggregating brain cell cultures. Here we show that following protein kinase C activator-induced demyelination, effective remyelination occurs. We found that mezerein or FGF-2 caused a transient increase in DNA synthesis following a pronounced decrease of the myelin markers myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphohydrolase. Both oligodendrocytes and astrocytes were involved in this mitogenic response. Within 17 days after demyelination, myelin was restored to the level of the untreated controls. Transient mitotic activity was indispensable for remyelination. The present results suggest that myelinating oligodendrocytes retain the capacity to reenter the cell cycle, and that this plasticity is important for the regeneration of the oligodendrocyte lineage and remyelination. Although it cannot be excluded that a quiescent population of oligodendrocyte precursor cells was present in the aggregates and able to proliferate, differentiate and remyelinate, we could not find evidence supporting this view.


Subject(s)
Brain/physiopathology , Demyelinating Diseases/chemically induced , Diterpenes , Enzyme Activation/physiology , Myelin Sheath/physiology , Protein Kinase C/metabolism , Terpenes/pharmacology , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , Animals , Becaplermin , Biomarkers , Brain/pathology , Cell Division/physiology , Cytarabine/pharmacology , DNA/biosynthesis , Demyelinating Diseases/physiopathology , Fetus , Fibroblast Growth Factor 2/pharmacology , In Vitro Techniques , Mitosis/physiology , Myelin Basic Protein/antagonists & inhibitors , Myelin Sheath/drug effects , Oligodendroglia/pathology , Oligodendroglia/physiology , Platelet-Derived Growth Factor/pharmacology , Proto-Oncogene Proteins c-sis , Rats
11.
Curr Protoc Pharmacol ; Chapter 12: Unit12.1, 2001 May.
Article in English | MEDLINE | ID: mdl-21965066

ABSTRACT

Culture preparations vary greatly in complexity, ranging from single isolated cells to three-dimensional histotypic cell structures. Besides cultures obtained directly from animal tissues (primary cultures), permanent cultures of continuously dividing (immortalized) cells have been established. This unit highlights both the advantages and disadvantages of a number in vitro approaches including primary cultures, continuous (permanent or immortal) cell lines, and contrasts culture techniques including suspension, attached (monolayer), and three-dimensional (aggregate) cultures in addition to explants. The basics of culture maintenance and propagation are covered (i.e., tissue dispersion, cell separation and purification, and passaging), and information is provided on the critical aspects of culturing cells, such as pH of the media, osmolality, humidity, and cell density. Also included is a troubleshooting section on how to cope with problems of contamination by bacteria, mycoplasma, toxic chemicals or foreign cell types.Culture preparations vary greatly in complexity, ranging from single isolated cells to three-dimensional histotypic cell structure.


Subject(s)
Cell Culture Techniques/methods , Tissue Culture Techniques/methods , Animals , Cell Count/methods , Cell Line, Transformed , Humans
12.
Neurotoxicology ; 21(4): 599-605, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11022867

ABSTRACT

Aggregating brain cell cultures of fetal rat telencephalon can be grown in a chemically defined medium for extended periods of time. After a phase of intense mitotic activity, these three-dimensional cell cultures undergo extensive morphological differentiation, including synaptogenesis and myelination. To study the developmental toxicity of organophosphorus compounds (OP), aggregating brain cell cultures were treated with parathion. Protein content and cell type-specific enzyme activities were not affected up to a concentration of 10(5) M. Gliosis, characterized by an increased staining for glial fibrillary acidic protein (GFAP), was observed in immature and in differentiated cells. In contrast, uridine incorporation and myelin basic protein (MBP) immunoreactivity revealed strong differences in sensitivity between these two developmental stages. These results are in agreement with the view that in vivo the development-dependent toxicity is not only due to changes in hepatic detoxification, but also to age-related modifications in the susceptibility of the different populations of brain cells. Furthermore, they underline the usefulness of histotypic culture systems with a high developmental potential, such as aggregating brain cell cultures, and stress the importance of applying a large range of criteria for testing the developmental toxicity of potential neurotoxicants.


Subject(s)
Brain/cytology , Insecticides/toxicity , Organophosphorus Compounds , Animals , Brain/drug effects , Cell Aggregation/drug effects , Cells, Cultured , Female , Humans , Pregnancy , Rats
13.
Toxicol Appl Pharmacol ; 165(3): 175-83, 2000 Jun 15.
Article in English | MEDLINE | ID: mdl-10873710

ABSTRACT

An in vitro model, the aggregating brain cell culture of fetal rat telencephalon, has been used to study the maturation-dependent sensitivity of brain cells to two organophosphorus pesticides (OPs), chlorpyrifos and parathion, and to their oxon derivatives. Immature (DIV 5-15) or differentiated (DIV 25-35) brain cells were treated continuously for 10 days. Acetylcholinesterase (AChE) inhibitory potency for the OPs was compared to that of eserine (physostigmine), a reversible AChE inhibitor. Oxon derivatives were more potent AChE inhibitors than the parent compounds, and parathion was more potent than chlorpyrifos. No maturation-dependent differences for AChE inhibition were found for chlorpyrifos and eserine, whereas for parathion and paraoxon there was a tendency to be more effective in immature cultures, while the opposite was true for chlorpyrifos-oxon. Toxic effects, assessed by measuring protein content as an index of general cytotoxicity, and various enzyme activities as cell-type-specific neuronal and glial markers (ChAT and GAD, for cholinergic and GABAergic neurons, respectively, and GS and CNP, for astrocytes and oligodendrocytes, respectively) were only found at more than 70% of AChE inhibition. Immature compared to differentiated cholinergic neurons appeared to be more sensitive to OP treatments. The oxon derivates were found to be more toxic on neurons than the parent compounds, and chlorpyrifos was more toxic than parathion. Eserine was not neurotoxic. These results indicate that inhibition of AChE remains the most sensitive macromolecular target of OP exposure, since toxic effects were found at concentrations in which AChE was inhibited. Furthermore, the compound-specific reactions, the differential pattern of toxicity of OPs compared to eserine, and the higher sensitivity of immature brain cells suggest that the toxic effects and inhibition of AChE are unrelated.


Subject(s)
Cell Differentiation/drug effects , Chlorpyrifos/pharmacology , Cholinesterase Inhibitors/pharmacology , Parathion/pharmacology , Phosphoric Diester Hydrolases , Telencephalon/drug effects , 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase , 2',3'-Cyclic-Nucleotide Phosphodiesterases/metabolism , Animals , Biomarkers , Cell Differentiation/physiology , Cells, Cultured , Chlorpyrifos/analogs & derivatives , Choline O-Acetyltransferase/metabolism , Dose-Response Relationship, Drug , Embryonic and Fetal Development , Glutamate Decarboxylase/metabolism , Glutamate-Ammonia Ligase/metabolism , Neuroglia/drug effects , Neuroglia/enzymology , Neurons/drug effects , Neurons/enzymology , Paraoxon/pharmacology , Parathion/analogs & derivatives , Physostigmine/pharmacology , Rats , Telencephalon/cytology , Telencephalon/embryology , Telencephalon/enzymology
14.
J Neurosci Res ; 59(4): 504-12, 2000 Feb 15.
Article in English | MEDLINE | ID: mdl-10679789

ABSTRACT

Several groups have demonstrated the existence of self-renewing stem cells in embryonic and adult mouse brain. In vitro, these cells proliferate in response to epidermal growth factor, forming clusters of nestin-positive cells that may be dissociated and subcultured repetitively. Here we show that, in stem cell clusters derived from rat embryonic striatum, cell proliferation decreased with increasing number of passages and in response to elevated concentrations of potassium (30 mM KCl). In monolayer culture, the appearance of microtubule-associated protein type-5-immunoreactive (MAP-5(+)) cells (presumptive neurons) in response to basic fibroblast growth factor (bFGF) was reduced at low cell density and with increasing number of passages. In the presence of bFGF, elevated potassium caused a more differentiated neuronal phenotype, characterized by an increased proportion of MAP-5(+) cells, extensive neuritic branching, and higher specific activity of glutamic acid decarboxylase. Dissociated stem cells were able to invade cultured brain cell aggregates containing different proportions of neurons and glial cells, whereas they required the presence of a considerable proportion of glial cells in the host cultures to become neurofilament H-positive. The latter observation supports the view that astrocyte-derived factors influence early differentiation of the neuronal cell lineage.


Subject(s)
Cell Differentiation/physiology , Corpus Striatum/cytology , Microtubule-Associated Proteins/metabolism , Neuroglia/physiology , Neurons/physiology , Stem Cells/physiology , Animals , Cell Differentiation/drug effects , Cells, Cultured , Coculture Techniques/methods , Corpus Striatum/drug effects , Corpus Striatum/embryology , Epidermal Growth Factor/pharmacology , Fibroblast Growth Factor 2/pharmacology , Mice , Microtubule-Associated Proteins/drug effects , Neuroglia/drug effects , Neurons/drug effects , Potassium Chloride/pharmacology , Rats , Stem Cells/drug effects
15.
J Biol Chem ; 274(50): 35881-8, 1999 Dec 10.
Article in English | MEDLINE | ID: mdl-10585473

ABSTRACT

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate the expression of many genes involved in lipid metabolism. The biological roles of PPARalpha and PPARgamma are relatively well understood, but little is known about the function of PPARbeta. To address this question, and because PPARbeta is expressed to a high level in the developing brain, we used reaggregated brain cell cultures prepared from dissociated fetal rat telencephalon as experimental model. In these primary cultures, the fetal cells initially form random aggregates, which progressively acquire a tissue-specific pattern resembling that of the brain. PPARs are differentially expressed in these aggregates, with PPARbeta being the prevalent isotype. PPARalpha is present at a very low level, and PPARgamma is absent. Cell type-specific expression analyses revealed that PPARbeta is ubiquitous and most abundant in some neurons, whereas PPARalpha is predominantly astrocytic. We chose acyl-CoA synthetases (ACSs) 1, 2, and 3 as potential target genes of PPARbeta and first analyzed their temporal and cell type-specific pattern. This analysis indicated that ACS2 and PPARbeta mRNAs have overlapping expression patterns, thus designating the ACS2 gene as a putative target of PPARbeta. Using a selective PPARbeta activator, we found that the ACS2 gene is transcriptionally regulated by PPARbeta, demonstrating a role for PPARbeta in brain lipid metabolism.


Subject(s)
Coenzyme A Ligases/genetics , Neurons/metabolism , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/physiology , Telencephalon/metabolism , Transcription Factors/genetics , Transcription Factors/physiology , Animals , Bezafibrate/pharmacology , Cell Aggregation , Cells, Cultured , Cycloheximide/pharmacology , DNA-Binding Proteins/metabolism , Dactinomycin/pharmacology , Embryo, Mammalian , Gene Expression Regulation/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Genes, Reporter , HeLa Cells , Humans , Isoenzymes/genetics , Kinetics , Neurons/cytology , Rats , Recombinant Fusion Proteins/biosynthesis , Telencephalon/cytology , Time Factors
16.
Ann Oncol ; 10(9): 1087-94, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10572607

ABSTRACT

BACKGROUND: The aim of this study was to assess the pharmacology, toxicity and activity of high-dose ifosfamide mesna +/- GM-CSF administered by a five-day continuous infusion at a total ifosfamide dose of 12-18 g/m2 in adult patients with advanced sarcomas. PATIENTS AND METHODS: Between January 1991 and October 1992 32 patients with advanced or metastatic sarcoma were entered the study. Twenty-seven patients were pretreated including twenty-three with prior ifosfamide at less than 8 g/m2 total dose/cycle. In 25 patients (27 cycles) extensive pharmacokinetic analyses were performed. RESULTS: The area under the plasma concentration-time curve (AUC) for ifosfamide increased linearly with dose while the AUC's of the metabolites measured in plasma by thin-layer chromatography did not increase with dose, particularly that of the active metabolite isophosphoramide mustard. Furthermore the AUC of the inactive carboxymetabolite did not increase with dose. Interpatient variability of pharmacokinetic parameters was high. Dose-limiting toxicity was myelosuppression at 18 g/m2 total dose with grade 4 neutropenia in five of six patients and grade 4 thrombocytopenia in four of six patients. Therefore the maximum tolerated dose was considered to be 18 g/m2 total dose. There was one CR and eleven PR in twenty-nine evaluable patients (overall response rate 41%). CONCLUSION: Both the activation and inactivation pathways of ifosfamide are non-linear and saturable at high-doses although the pharmacokinetics of the parent drug itself are dose linear. Ifosfamide doses greater than 14-16 g/m2 per cycle appear to result in a relative decrease of the active metabolite isophosphoramide mustard. These data suggest a dose-dependent saturation or even inhibition of ifosfamide metabolism by increasing high dose ifosfamide and suggest the need for further metabolic studies.


Subject(s)
Antineoplastic Agents, Alkylating/pharmacokinetics , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacokinetics , Ifosfamide/pharmacokinetics , Mesna/pharmacokinetics , Protective Agents/pharmacokinetics , Sarcoma/drug therapy , Adult , Aged , Antineoplastic Agents, Alkylating/blood , Antineoplastic Agents, Alkylating/toxicity , Antineoplastic Agents, Alkylating/urine , Area Under Curve , Dose-Response Relationship, Drug , Female , Humans , Ifosfamide/blood , Ifosfamide/toxicity , Ifosfamide/urine , Male , Mesna/toxicity , Middle Aged , Prodrugs/pharmacokinetics , Protective Agents/toxicity , Remission Induction , Time Factors
17.
J Cereb Blood Flow Metab ; 19(9): 1051-9, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10478657

ABSTRACT

The role of cell type-specific Na+,K+-ATPase isozymes in function-related glucose metabolism was studied using differentiated rat brain cell aggregate cultures. In mixed neuron-glia cultures, glucose utilization, determined by measuring the rate of radiolabeled 2-deoxyglucose accumulation, was markedly stimulated by the voltage-dependent sodium channel agonist veratridine (0.75 micromol/L), as well as by glutamate (100 micromol/L) and the ionotropic glutamate receptor agonist N-methyl-D-aspartate (NMDA) (10 micromol/L). Significant stimulation also was elicited by elevated extracellular potassium (12 mmol/L KCl), which was even more pronounced at 30 mmol/L KCl. In neuron-enriched cultures, a similar stimulation of glucose utilization was obtained with veratridine, specific ionotropic glutamate receptor agonists, and 30 mmol/L but not 12 mmol/L KCl. The effects of veratridine, glutamate, and NMDA were blocked by specific antagonists (tetrodotoxin, CNQX, or MK801, respectively). Low concentrations of ouabain (10(-6) mol/L) prevented stimulation by the depolarizing agents but reduced only partially the response to 12 mmol/L KCl. Together with previous data showing cell type-specific expression of Na+,K+-ATPase subunit isoforms in these cultures, the current results support the view that distinct isoforms of Na+,K+-ATPase regulate glucose utilization in neurons in response to membrane depolarization, and in glial cells in response to elevated extracellular potassium.


Subject(s)
Glucose/metabolism , Neuroglia/physiology , Neurons/physiology , Sodium-Potassium-Exchanging ATPase/physiology , Animals , Biological Transport/physiology , Cells, Cultured , Isoenzymes/physiology , Membrane Potentials , Rats , Rats, Sprague-Dawley
18.
Neurosci Lett ; 266(2): 89-92, 1999 May 07.
Article in English | MEDLINE | ID: mdl-10353334

ABSTRACT

Hyperammonemia in the brain leads to poorly understood alterations of nitric oxide (NO) synthesis. Arginine, the substrate of nitric oxide synthases, might be recycled from the citrulline produced with NO by argininosuccinate synthetase (AS) and argininosuccinate lyase (AL). The regulation of AS and AL genes during hyperammonemia is unknown in the brain. We used brain cell aggregates cultured from dissociated telencephalic cortex of rat embryos to analyze the regulation of AS and AL genes in hyperammonemia. Using RNase protection assay and non-radioactive in situ hybridization on aggregate cryosections, we show that both AS and AL genes are induced in astrocytes but not in neurons of aggregates exposed to 5 mM NH4Cl. Our work suggests that the hyperammonemic brain might increase its recycling of citrulline to arginine.


Subject(s)
Ammonia/blood , Argininosuccinate Lyase/genetics , Argininosuccinate Synthase/genetics , Brain/metabolism , Gene Expression Regulation, Developmental/physiology , Gene Expression Regulation, Enzymologic/physiology , Animals , Brain/cytology , Brain/embryology , Cell Aggregation/physiology , Cells, Cultured , Embryonic and Fetal Development/physiology , Rats
19.
Brain Res Dev Brain Res ; 115(1): 9-16, 1999 Jun 08.
Article in English | MEDLINE | ID: mdl-10366697

ABSTRACT

The involvement of voltage-gated calcium channels in the survival of immature CNS neurons was studied in aggregating brain cell cultures by examining cell type-specific effects of various channel blockers. Nifedipine (10 microM), a specific blocker of L-type calcium channels, caused a pronounced and irreversible decrease of glutamic acid decarboxylase activity, whereas the activity of choline acetyltransferase was significantly less affected. Flunarizine (1-10 microM, a relatively unspecific ion channel blocker) elicited similar effects, that were attenuated by NMDA. The glia-specific marker enzymes, glutamine synthetase and 2',3'-cyclic nucleotide 3'-phosphohydrolase, were affected only after treatment with high concentrations of nifedipine (50 microM) or NiCl2 (100 microM, shown to block T-type calcium channels). Nifedipine (50 microM), NiCl2 (100 microM), and flunarizine (5 microM) also caused a significant increase in the soluble nucleosome concentration, indicating increased apoptotic cell death. This effect was prevented by cycloheximide (1 microM). Furthermore, the combined treatment with calcicludine (10 nM, blocking L-type calcium channels) and funnel-web spider toxin-3.3 (100 nM, blocking T-type channels) also caused a significant increase in free nucleosomes as well as a decrease in glutamic acid decarboxylase activity. In contrast, cell viability was not affected by peptide blockers specific for N-, P-, and/or Q-type calcium channels. Highly differentiated cultures showed diminished susceptibility to nifedipine and flunarizine. The present data suggest that the survival of immature neurons, and particularly that of immature GABAergic neurons, requires the sustained entry of Ca2+ through voltage-gated calcium channels.


Subject(s)
Calcium Channel Blockers/pharmacology , Cellular Senescence/drug effects , Ion Channel Gating , Neurons/drug effects , gamma-Aminobutyric Acid/physiology , Acetylcholine/physiology , Animals , Cell Death/drug effects , Cells, Cultured , Cycloheximide/pharmacology , Flunarizine/pharmacology , Membrane Potentials/drug effects , Nifedipine/pharmacology , Rats , Rats, Sprague-Dawley
20.
Neurotoxicology ; 20(1): 41-8, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10091857

ABSTRACT

The effects of subchronical applications of the mycotoxin Fumonisin B1 (FB1) were analyzed in vitro, using aggregating cell cultures of fetal rat telencephalon as a model. As cells in the aggregates developed from an immature state to a highly differentiated state, with synapse and compact myelin formation, it was possible to study the effects of FB1 at different developmental stages. The results showed that FB1 did not cause cell loss and it had no effects on neurons. However it decreased strongly the total content of myelin basic protein, the main constituent of the myelin sheath, during the myelination period (DIV 18-28). The loss of myelin was not accompanied by a loss of oligodendrocytes, the myelinating cells. However FB1 had effects on the maturation of oligodendrocytes, as revealed by a decrease in the expression of galactocerebroside, and on the compaction of myelin, as shown by a reduction of the expression of the mnyelin/oligodendrocyte glycoprotein MOG. The content of the cytoskeletal component glial fibrillary acidic protein (GFAP) was decreased in differentiated astrocytes, exclusively, while neurons were not affected by 40 microM of FB1 applied continuously for 10 days. In summary, FB1 selectively affected glial cells. In particular, FB1 delayed oligodendrocyte development and impaired myelin formation and deposition.


Subject(s)
Brain/cytology , Carboxylic Acids/pharmacology , Fumonisins , Mycotoxins/pharmacology , Myelin Sheath/drug effects , Neurons/drug effects , Animals , Apoptosis/drug effects , Astrocytes/drug effects , Blotting, Western , Brain/drug effects , Cell Aggregation/drug effects , Cells, Cultured , Glial Fibrillary Acidic Protein/biosynthesis , Immunohistochemistry , In Situ Nick-End Labeling , Microglia/drug effects , Microglia/ultrastructure , Myelin Basic Protein/biosynthesis , Myelin Basic Protein/metabolism , Oligodendroglia/drug effects , Rats , Thymidine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...